Keywords: alteon, may, drop, pimagedine, niddm, been, advised

Alteon May Drop Pimagedine In NIDDM

Article | 19 March 1998

Print This

Alteon has been advised that it should discontinue its Phase III trialof pimagedine in non-insulin-dependent (type II) diabetes patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in